Senate Bill No. [insert number], introduced by E. Boldman, aims to enhance health insurance coverage for individuals with advanced metastatic cancer by prohibiting insurers from requiring patients to try alternative prescription drugs before covering FDA-approved treatments. This requirement is contingent upon the prescribing aligning with the most cost-effective therapy as per National Comprehensive Cancer Network guidelines. The bill also defines "advanced metastatic cancer" and "associated conditions" to ensure that coverage aligns with best practices supported by peer-reviewed literature.

Furthermore, the bill amends several sections of the Montana Code Annotated (MCA), including 2-18-704, 33-31-111, and 33-35-306, to mandate coverage for metastatic cancer treatment in insurance contracts. It clarifies the applicability of insurance laws to health maintenance organizations, ensuring compliance with network adequacy and quality assurance standards. Additionally, the bill specifies that self-funded multiple employer welfare arrangements are subject to certain provisions within Title 33, while introducing a codification instruction to integrate the new legal language into Title 33, chapter 22, part 1, thereby officially recognizing it within Montana's insurance regulatory framework.

Statutes affected:
LC Text: 2-18-704, 33-31-111, 33-35-306
SB0422_1(1): 2-18-704, 33-31-111, 33-35-306
SB0422_1(2): 2-18-704, 33-31-111, 33-35-306
SB0422_1(3): 2-18-704, 33-31-111, 33-35-306
SB0422_1(4): 2-18-704, 33-31-111, 33-35-306
SB0422_1: 2-18-704, 33-31-111, 33-35-306
SB0422_2(1): 2-18-704, 33-31-111, 33-35-306
SB0422_2(2): 2-18-704, 33-31-111, 33-35-306
SB0422_2(3): 2-18-704, 33-31-111, 33-35-306
SB0422_2(4): 2-18-704, 33-31-111, 33-35-306
SB0422_2(5): 2-18-704, 33-31-111, 33-35-306
SB0422_2(6): 2-18-704, 33-31-111, 33-35-306
SB0422_2(7): 2-18-704, 33-31-111, 33-35-306
SB0422_2(8): 2-18-704, 33-31-111, 33-35-306
SB0422_2: 2-18-704, 33-31-111, 33-35-306